Showing results (91-100 of 344) with videos related to
Sort By:
Pageof 35
Cancer Research|June 14, 2014
The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?Anne Marie Lennon, Christopher L Wolfgang, Marcia Irene Canto, et al.Elife|February 17, 2025
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscapeAshley L Cook, Surojit Sur, Laura Dobbyn, et al.Biorxiv : the Preprint Server for Biology|August 7, 2023
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, et al.The Journal of Pathology|December 3, 2013
Whole-exome sequencing of pancreatic neoplasms with acinar differentiationYuchen Jiao, Raluca Yonescu, G Johan A Offerhaus, et al.Cancer Cell|February 1, 2003
Histone modifications and silencing prior to DNA methylation of a tumor suppressor geneKurtis E Bachman, Ben Ho Park, Ina Rhee, et al.Journal of Bacteriology|June 26, 2007
Spore coat architecture of Clostridium novyi NT sporesMarco Plomp, J Michael McCaffery, Ian Cheong, et al.Gastroenterology|July 8, 2008
Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patientsFrank Diehl, Kerstin Schmidt, Kristine H Durkee, et al.Proceedings of the National Academy of Sciences of the United States of America|March 18, 2021
Targeting loss of heterozygosity for cancer-specific immunotherapyMichael S Hwang, Brian J Mog, Jacqueline Douglass, et al.Cancer Discovery|May 22, 2025
Detection of cancers three years prior to diagnosis using plasma cell-free DNAYuxuan Wang, Corinne E Joshu, Samuel D Curtis, et al.Proceedings of the National Academy of Sciences of the United States of America|September 30, 2010
Accumulation of driver and passenger mutations during tumor progressionIvana Bozic, Tibor Antal, Hisashi Ohtsuki, et al.Pageof 35